Koninklijke Philips (PHG) Stock Forecast & Price Target

$26.39 +0.01 (+0.04%)

(As of 11/22/2024 ET)

Koninklijke Philips - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 5 Analyst Ratings

Sell
0

Hold
4

Buy
1

Based on 5 Wall Street analysts who have issued ratings for Koninklijke Philips in the last 12 months, the stock has a consensus rating of "Hold." Out of the 5 analysts, 4 have given a hold rating, and 1 has given a buy rating for PHG.

Consensus Price Target

N/A

Get the Latest News and Ratings for PHG and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Koninklijke Philips and its competitors.

PHG Analyst Ratings Over Time

Type	Current Forecast 11/25/23 to 11/24/24	1 Month Ago 10/26/23 to 10/25/24	3 Months Ago 8/27/23 to 8/26/24	1 Year Ago 11/25/22 to 11/25/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	1 Buy rating(s)	1 Buy rating(s)	1 Buy rating(s)	2 Buy rating(s)
Hold	4 Hold rating(s)	3 Hold rating(s)	3 Hold rating(s)	3 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	N/A	N/A	N/A	N/A
Forecasted Upside	N/A	N/A	N/A	N/A
Consensus Rating	Hold	Hold	Hold	Hold

JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)

Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.

Get your free guide NOW before it's too late.

PHG Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

PHG Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Koninklijke Philips Stock vs. The Competition

Type	Koninklijke Philips	Medical Companies	S&P 500
Consensus Rating Score	2.20	2.80	2.50
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	N/A	27,073.49% Upside	7.66% Upside
News Sentiment Rating	Positive News See Recent PHG News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target
10/29/2024	Jefferies Financial Group 2 of 5 stars	Upgrade	Underperform ➝ Hold
5/13/2024	Sanford C. Bernstein 3 of 5 stars	Upgrade	Market Perform ➝ Outperform
5/7/2024	BNP Paribas 3 of 5 stars	Upgrade	Underperform ➝ Neutral
4/30/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Sell ➝ Neutral
4/30/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Underweight ➝ Neutral
7/12/2023	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy
7/7/2023	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target		€19.00
4/25/2023	Societe Generale Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Sell ➝ Hold
1/17/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Equal Weight ➝ Equal Weight	€17.00 ➝ €16.00
1/10/2023	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	€19.00 ➝ €18.50

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 10:47 AM ET.

Should I Buy Koninklijke Philips Stock? PHG Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, November 4, 2024. Please send any questions or comments about these Koninklijke Philips pros and cons to contact@marketbeat.com.

Koninklijke Philips
Bull Case

Here are some ways that investors could benefit from investing in Koninklijke Philips:

Koninklijke Philips has shown consistent growth in revenue and earnings, indicating a strong financial performance.
The company's recent positive earnings report, with $0.32 earnings per share and $4.80 billion in revenue, demonstrates financial stability.
With a market capitalization of $30.75 billion, Koninklijke Philips is a significant player in the technology sector, offering stability and potential growth.
The stock price of Koninklijke Philips has been steadily increasing, reaching $32.71, which may indicate positive investor sentiment and potential for further gains.
Analysts predict that Koninklijke Philips will post 1.57 EPS for the current fiscal year, suggesting future profitability and growth potential.

Koninklijke Philips
Bear Case

Investors should be bearish about investing in Koninklijke Philips for these reasons:

Despite recent positive performance, Koninklijke Philips has a negative net margin of 2.35%, indicating potential financial challenges.
The company's P/E ratio of -34.08 may raise concerns about overvaluation or market expectations that could impact stock performance.
Koninklijke Philips has a debt-to-equity ratio of 0.60, which suggests a moderate level of financial leverage that could affect future financial health.
The company's beta of 0.73 indicates lower volatility compared to the market average, potentially limiting short-term trading opportunities for investors.
While Koninklijke Philips has shown growth, competition in the technology sector is intense, posing challenges for sustained market share and profitability.

PHG Forecast - Frequently Asked Questions

: 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Koninklijke Philips in the last twelve months. There are currently 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" PHG shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PHG, but not buy additional shares or sell existing shares.
: According to analysts, Koninklijke Philips's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.
: Over the previous 90 days, Koninklijke Philips's stock had 1 upgrade by analysts.
: Koninklijke Philips has been rated by research analysts at Jefferies Financial Group in the past 90 days.
: Analysts like Koninklijke Philips less than other "medical" companies. The consensus rating for Koninklijke Philips is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how PHG compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Ever heard of this 8-day bitcoin profit window? (Ad)

Did you know Bitcoin almost always soars higher during an 8-Day Profit Window? Most people have no clue… But for over a year now, some of our top students have had the chance to cash in with some incredible gains during this 8-day window.

It’s coming up quick.

This page (NYSE:PHG) was last updated on 11/24/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Koninklijke Philips (PHG) Stock Forecast & Price Target